Sagimet Biosciences Inc.

SGMT | NASDAQ

Price Alert Chart Builder DCF Calculator

$11.23

+$0.43 (+3.98%)

Sep 22, 2026, 10:50 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	35.02M	75.84M	75.14M	158K	56.73M	68.7M
Short-Term Investments	78.1M	75.41M	19.76M	32.19M	n/a	n/a
Long-Term Investments	n/a	7.41M	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	27K	27K	27K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	481K	463K	397K	34K	1.51M	36K
Total Current Assets	116.4M	152.77M	96.65M	32.79M	58.66M	68.74M
Property-Plant & Equipment	78K	77K	73K	212K	342K	194K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	78K	7.49M	73K	239K	369K	221K
Total Assets	116.48M	160.26M	96.72M	33.03M	59.03M	68.96M
Account Payables	1.31M	1.43M	186K	1.13M	761K	513K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	27K	5K	556K	57K	185K	243K
Total Current Liabilities	5.1M	4.45M	5.65M	5.28M	2.44M	1.91M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	214.62M	214.63M	202.89M
Total Long-Term Liabilities	n/a	n/a	n/a	214.7M	214.85M	202.96M
Total Liabilities	5.1M	4.45M	5.65M	219.98M	217.29M	204.87M
Total Debt	78K	78K	65K	211K	348K	210K
Book Value	111.38M	155.81M	91.07M	-186.95M	-158.26M	-135.91M
Book Value Per Share	3.44	4.97	5.01	-8.43	-7.14	-6.13
Common Stock	3K	3K	2K	1K	1K	1K
Retained Earnings	-346.35M	-295.31M	-249.74M	-221.87M	-191.37M	-166.93M
Comprehensive Income	120K	230K	30K	-84K	n/a	n/a
Shareholders Equity	111.38M	155.81M	91.07M	-186.95M	-158.26M	-135.91M
Total Investments	78.1M	82.82M	19.76M	32.19M	n/a	n/a